Rajan Anand

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents

Zhonghui Lu, Gregory R. Ott, Rajan Anand et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 56 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11

Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach

Jonathan E. Wilson, Ravi Kurukulasuriya, Mikhail Reibarkh et al. · ACS Medicinal Chemistry Letters · 2016 · 52 citations · Full text

Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist

Chu‐Biao Xue, Hao Feng, Ganfeng Cao et al. · ACS Medicinal Chemistry Letters · 2011 · 48 citations · Full text

Chemotaxis Activity, Molecular Pharmacology, Potent Human Ccr2 +13

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents

Gregory R. Ott, Naoyuki Asakawa, Zhonghui Lu et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 46 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +11

Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist

Chu‐Biao Xue, Anlai Wang, Qi Han et al. · ACS Medicinal Chemistry Letters · 2011 · 45 citations · Full text